IMC Share Price

Open 0.28 Change Price %
High 0.28 1 Day -0.02 -7.14
Low 0.26 1 Week -0.04 -13.33
Close 0.26 1 Month -0.02 -7.14
Volume 114301 1 Year -0.17 -39.53
52 Week High 0.45
52 Week Low 0.22
IMC Important Levels
Resistance 2 0.28
Resistance 1 0.27
Pivot 0.27
Support 1 0.25
Support 2 0.24
ASX Australia Most Active Stocks
AGO 0.04 0.00%
AGO 0.04 0.00%
AGO 0.04 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
MLX 0.70 2.94%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
DDT 0.02 100.00%
PMQ 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
GPP 0.03 50.00%
TDO 0.06 50.00%
PUN 0.04 33.33%
PUN 0.04 33.33%
More..
ASX Australia Top Losers Stocks
GGE 0.00 -100.00%
GGE 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
More..

Immuron Ltd (ASX: IMC)

IMC Technical Analysis 5
As on 17th Jan 2017 IMC Share Price closed @ 0.26 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.33 & Strong Sell for SHORT-TERM with Stoploss of 0.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
IMC Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
IMC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.immuron.com
IMC Address
IMC
1233 High Street
Suite 1
Armadale, VIC 3143
Australia
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
IMC Latest News
Update on Valuation Formula's For Immuron Limited (ASX:IMC)   Marion Business Daily   - 04th Jan 17
Immuron Receives $1.59M R&D Tax Concession Refund   GlobeNewswire (press release)   - 29th Nov 16
Immuron Announces Availability of RedChip Conference Presentation   GlobeNewswire (press release)   - 25th Jul 16
Immuron to Cooperate with Leading Australian Universities on Autism Research   GlobeNewswire (press release)   - 20th Jul 16
Immuron Significantly Expands US Distribution Reach with McKesson Agreement   GlobeNewswire (press release)   - 29th Jun 16
Immuron Ltd has no safety issues in Phase II fatty liver trial   Proactive Investors Australia   - 26th May 16
Immuron Ltd tap into U.S. market for travellers' tablets with CVS Pharmacy   Proactive Investors Australia   - 15th Apr 16
Immuron Limited Starts NASH Companion Diagnostic Collaboration With OWL S.L.   GlobeNewswire (press release)   - 10th Nov 15
What's Happening to the Share Price of Immuron Ltd?   Daily Reckoning - Australian Edition   - 24th Aug 15
Immuron Limited signs U.S. distribution agreement for diarrhoea treatment   Proactive Investors Australia   - 04th Aug 15
Interactive Technical Analysis Chart Immuron Ltd ( IMC ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Immuron Ltd
IMC Business Profile
Immuron Limited, a biopharmaceutical company, is engaged in the research and development, and sale of polyclonal antibodies for the treatment and prevention of various diseases in Australia and internationally. The company’s platform technology enables the development of medicines that target a range of medical needs, including infectious diseases, immune mediated disorders, and cancers. It commercializes its platform derived products through a range of regulatory pathways, including prescription, medical foods, over-the-counter medicines, and dietary supplements. The company offers Travelan, a natural product for the prevention of Travellers’ Diarrhoea. It is also developing IMM 272, a bovine colostrum powder to prevent rotavirus diarrhea; IMM 124-E, a natural product for the treatment of fatty liver and non-alcoholic steatohepatitis/type 2 diabetes; IMM 529 for the treatment of clostridium difficile infection; IMM-363 to treat of side effects caused by chemotherapy or radiation; and IMM-160 to reduce tumour size and suppress liver cancer. Immuron Limited was founded in 1994 and is based in Armadale, Australia.